peposertib
Showing 1 - 8 of 8
Metastatic Leiomyosarcoma, Metastatic Sarcoma, Metastatic Soft Tissue Sarcoma Trial (Computed Tomography, Magnetic Resonance
Not yet recruiting
- Metastatic Leiomyosarcoma
- +5 more
- Computed Tomography
- +3 more
- (no location specified)
Feb 2, 2023
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Biospecimen
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Biopsy
- +6 more
- (no location specified)
Jan 14, 2023
Neuroendocrine Tumor Trial in United States (Lutetium Lu 177 Dotatate, Peposertib)
Recruiting
- Neuroendocrine Neoplasm
- Biospecimen Collection
- +4 more
-
Duarte, California
- +3 more
Jan 12, 2023
Healthy Trial in Gauting, Neu-Ulm (Peposertib)
Completed
- Healthy
- Peposertib
-
Gauting, Germany
- +1 more
May 11, 2021
Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in
Recruiting
- Fallopian Tube Carcinosarcoma
- +28 more
- Pegylated Liposomal Doxorubicin Hydrochloride
- Peposertib
-
Aurora, Colorado
- +7 more
Sep 2, 2022
Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous
Suspended
- Advanced Head and Neck Squamous Cell Carcinoma
- +17 more
- Intensity-Modulated Radiation Therapy
- Peposertib
-
Gilbert, Arizona
- +19 more
Dec 31, 2022
Locally Advanced Pancreatic Adenocarcinoma, Locally Advanced Unresectable Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer
Recruiting
- Locally Advanced Pancreatic Adenocarcinoma
- +6 more
- Hypofractionated Radiation Therapy
- +2 more
-
Duarte, California
- +29 more
Apr 2, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Lymph Nodes, Metastatic Prostate Carcinoma Trial in
Recruiting
- Castration-Resistant Prostate Carcinoma
- +3 more
- Avelumab
- +4 more
-
Los Angeles, California
- +22 more
Feb 2, 2023